Annemiek B. van Spriel

Annemiek B. van Spriel

Auto-generated profile, based on publicly available information

Annemiek B. van Spriel

Radboud University Medical Center

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 October 2009 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
BFBart Ferwerda
Bart Ferwerda
GFGerben Ferwerda
Gerben Ferwerda
TPTheo Plantinga
Theo Plantinga
JWJanet A. Willment
Janet A. Willment
ASAnnemiek B. van Spriel
Annemiek B. van Spriel
MNMihai G. Netea
Mihai G. Netea
Mucocutaneous fungal infections are typically found in patients who have no known immune defects. We describe a family in which four women who were affected by either recurrent vulvovaginal candidiasis or onychomycosis had the early-stop-codon mutation Tyr238X in the β-glucan receptor dectin-1. The mutated form of dectin-1 was poorly expressed, did not mediate β-glucan binding, and led to defective production of cytokines (interleukin-17, tumor necrosis factor, and interleukin-6) after stimulation with β-glucan or Candida albicans. In contrast, fungal phagocytosis and fungal killing were normal in the patients, explaining why dectin-1 deficiency was not associated with invasive fungal infections and highlighting the specific role of dectin-1 in human mucosal antifungal defense.

1 April 2001 in Trends in Immunology
Verified
Journal Article
Closed access
MEMarjolein van Egmond
Marjolein van Egmond
CDCora A Damen
Cora A Damen
ASAnnemiek B van Spriel
Annemiek B van Spriel
Gestur VidarssonGestur Vidarsson
Gestur Vidarsson
EGEvert van Garderen
Evert van Garderen
JWJan G.J van de Winkel
Jan G.J van de Winkel

1 September 2009 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
TPTheo Plantinga
Theo Plantinga
WVWalter J. F. M. van der Velden
Walter J. F. M. van der Velden
BFBart Ferwerda
Bart Ferwerda
ASAnnemiek B. van Spriel
Annemiek B. van Spriel
GAGosse Adema
Gosse Adema
MNMihai G. Netea
Mihai G. Netea
Background. Intensive treatment of hematological malignancies with hematopoietic stem cell transplantation (HSCT) is accompanied by a high incidence o

1 November 2003 in Trends in Immunology
Verified
Journal Article
Closed access
JTJacqueline M. Tarrant
Jacqueline M. Tarrant
LRLorraine Robb
Lorraine Robb
ASAnnemiek B. van Spriel
Annemiek B. van Spriel
MWMark D. Wright
Mark D. Wright

15 April 2001 in Blood
Verified
Journal Article
Open access
ASAnnemiek B. van Spriel
Annemiek B. van Spriel
JLJeanette H.W. Leusen
Jeanette H.W. Leusen
MEMarjolein van Egmond
Marjolein van Egmond
HDHenry B. P. M. Dijkman
Henry B. P. M. Dijkman
KAKarel J. M. Assmann
Karel J. M. Assmann
JWJan G. J. van de Winkel
Jan G. J. van de Winkel
Receptors for human immunoglobulin (Ig)G and IgA initiate potent cytolysis of antibody (Ab)-coated targets by polymorphonuclear leukocytes (PMNs). Mac-1 (complement receptor type 3, CD11b/CD18) has previously been implicated in receptor cooperation with Fc receptors (FcRs). The role of Mac-1 in FcR-mediated lysis of tumor cells was characterized by studying normal human PMNs, Mac-1–deficient mouse PMNs, and mouse PMNs transgenic for human FcR. All PMNs efficiently phagocytosed Ab-coated particles. However, antibody-dependent cellular cytotoxicity (ADCC) was abrogated in Mac-1−/− PMNs and in human PMNs blocked with anti–Mac-1 monoclonal Ab (mAb). Mac-1−/− PMNs were unable to spread on Ab-opsonized target cells and other Ab-coated surfaces. Confocal laser scanning and electron microscopy revealed a striking difference in immunologic synapse formation between Mac-1−/− and wild-type PMNs. Also, respiratory burst activity could be measured outside membrane-enclosed compartments by using Mac-1−/− PMNs bound to Ab-coated tumor cells, in contrast to wild-type PMNs. In summary, these data document an absolute requirement of Mac-1 for FcR-mediated PMN cytotoxicity toward tumor targets. Mac-1−/− PMNs exhibit defective spreading on Ab-coated targets, impaired formation of immunologic synapses, and absent tumor cytolysis.

17 July 2015 in Scientific Reports
Verified
Journal Article
Open access
MZMalou Zuidscherwoude
Malou Zuidscherwoude
FGFabian Göttfert
Fabian Göttfert
VDVera Marie E. Dunlock
Vera Marie E. Dunlock
CFCarl Figdor
Carl Figdor
Geert van den BogaartGeert van den Bogaart
Geert van den Bogaart
ASAnnemiek B. van Spriel
Annemiek B. van Spriel
The spatial organization of membrane proteins in the plasma membrane is critical for signal transduction, cell communication and membrane trafficking. Tetraspanins organize functional higher-order protein complexes called ‘tetraspanin-enriched microdomains (TEMs)’ via interactions with partner molecules and other tetraspanins. Still, the nanoscale organization of TEMs in native plasma membranes has not been resolved. Here, we elucidated the size, density and distribution of TEMs in the plasma membrane of human B cells and dendritic cells using dual color stimulated emission depletion (STED) microscopy. We demonstrate that tetraspanins form individual nanoclusters smaller than 120 nm and quantified that a single tetraspanin CD53 cluster contains less than ten CD53 molecules. CD53 and CD37 domains were adjacent to and displayed only minor overlap with clusters containing tetraspanins CD81 or CD82. Moreover, CD53 and CD81 were found in closer proximity to their partners MHC class II and CD19 than to other tetraspanins. Although these results indicate that tetraspanin domains are adjacently positioned in the plasma membrane, they challenge the current view of the tetraspanin web of multiple tetraspanin species organized into a single domain. This study increases the molecular understanding of TEMs at the nanoscale level which is essential for comprehending tetraspanin function in cell biology.